Title:
NOVEL DIALLYLMETHYLAMINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2002/067918
Kind Code:
A1
Abstract:
A diabetes remedy, preventive for diabetic chronic complications, or antiobestic agent, characterized by containing as the active ingredient a compound represented by the general formula (I): (I) (wherein Ar represents optionally substituted aryl, etc.; R?1¿ represents optionally substituted C¿1-10? alkyl, etc.; R?2¿ represents hydrogen, etc.; R?3¿ represents optionally substituted C¿1-10? alkyl, etc.; R?4¿ represents hydrogen, etc.; R?5¿ represents hydrogen, etc.; R?6¿ represents an optionally substituted, 5- or 6-membered, heterocyclic group, etc.; and W represents a single bond, etc.) or a medicinally acceptable salt or ester of the compound.
Inventors:
NISHIMURA TERUYUKI (JP)
NAGASE TOSHIO (JP)
EIKI JUN-ICHI (JP)
NAGASE TOSHIO (JP)
EIKI JUN-ICHI (JP)
Application Number:
PCT/JP2002/001810
Publication Date:
September 06, 2002
Filing Date:
February 27, 2002
Export Citation:
Assignee:
BANYU PHARMA CO LTD (JP)
NISHIMURA TERUYUKI (JP)
NAGASE TOSHIO (JP)
EIKI JUN-ICHI (JP)
NISHIMURA TERUYUKI (JP)
NAGASE TOSHIO (JP)
EIKI JUN-ICHI (JP)
International Classes:
A61K31/165; A61K31/167; A61K31/18; A61K31/341; A61K31/381; A61K31/4035; A61K31/405; A61K31/4168; A61K31/4184; A61K31/426; A61K31/427; A61K31/428; A61K31/437; A61K31/44; A61K31/4402; A61K31/4409; A61K31/443; A61K31/4436; A61K31/4439; A61K31/445; A61K31/4453; A61K31/451; A61K31/47; A61K31/472; A61K31/495; A61K31/497; A61K31/5375; A61P3/04; A61P3/10; A61P43/00; C07C237/04; C07C311/05; C07C311/51; C07D209/08; (IPC1-7): A61K31/165; A61K31/167; A61K31/18; A61K31/341; A61K31/381; A61K31/4035; A61K31/405; A61K31/4168; A61K31/4184; A61K31/426; A61K31/427; A61K31/428; A61K31/437; A61K31/44; A61K31/4402; A61K31/4409; A61K31/443; A61K31/4436; A61K31/4439; A61K31/445; A61K31/4453; A61K31/451; A61K31/47; A61K31/472; A61K31/495; A61K31/497; A61K31/5375; A61P3/04; A61P3/10; A61P43/00; C07C237/20; C07C311/05; C07C311/51; C07D209/08; C07D209/20; C07D211/16; C07D211/46; C07D211/58; C07D211/62; C07D213/38; C07D213/40; C07D213/42; C07D213/56; C07D213/61; C07D213/74; C07D213/75; C07D215/08; C07D217/06; C07D217/24; C07D233/88; C07D235/30; C07D277/82; C07D295/18; C07D307/52; C07D333/20; C07D401/12; C07D403/12; C07D405/12; C07D409/06; C07D409/12; C07D417/12; C07D471/04
Domestic Patent References:
| WO1998019998A2 | 1998-05-14 | |||
| WO1999038501A2 | 1999-08-05 | |||
| WO1998035957A1 | 1998-08-20 |
Foreign References:
| EP0945439A1 | 1999-09-29 | |||
| EP0955293A1 | 1999-11-10 | |||
| EP0528172A1 | 1993-02-24 | |||
| JP2001131175A | 2001-05-15 |
Other References:
DATABASE CAPLUS [online] AMERICAN CHEMICAL SOCIETY (ACS), (COLUMBUS, OHIO, USA); KUBOTA HITOSHI ET AL.: "Stereospecific amination by dynamic kinetic resolution utilizing 2-oxoimidazolidine-4-carboxylate as a novel chiral auxiliary", XP002953577, accession no. STN Database accession no. 123:228825
Attorney, Agent or Firm:
BANYU PHARMACEUTICAL CO., LTD. (Tokyo, Tokyo, JP)
Download PDF: